DAWN News and Press, Day One Biopharmaceuticals Inc. From 06/14/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Day One Biopharmaceuticals ( DAWN ) stock is gaining on Tuesday despite stock offering news. This is likely due to positive clinical trial results from Monday. The company’s stock is experiencing heavy tra...

Redbox Entertainment (RDBX) -21%. Hillstream BioPharma (HILS) -13%. DBV Technologies (DBVT) -11%. Day One Biopharmaceuticals (DAWN) -8% on $125M share offering. AeroClean Technologies (AERC) -8%. MicroStrategy (MSTR) -7% Bitcoin and ether deepen their slump, pulling MicroS...

Day One Biopharmaceuticals (NASDAQ:DAWN) shares dropped 13% pre-market after the biopharmaceutical company launched an underwritten public offering of $125M worth of shares of its common stock. Terms of the offering, including pricing, are yet to be disclosed. Underwriters may be gr...

SOUTH SAN FRANCISCO, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced th...

After more than doubling in value on Monday in reaction to encouraging early data for a brain tumor candidate in children, clinical-stage biotech Day One Biopharmaceuticals (DAWN) is trading lower in the pre-market currently on below-average volume. Initial results from a pivotal Phase 2 tria...

Wall Street suffered another major decline on Monday, as investors continued to worry about inflation and the prospect that the Federal Reserve would accelerate its program to increase interest rates. The slide sent the Dow lower by nearly 900 points, while the Nasdaq plunged 4.7%. While stoc...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In another rather ugly session in today’s equity markets, it’s good practice to look for winners. Today, investors in  Day One Biopharmaceuticals  (NASDAQ: DAWN ) are definitely winning. As ...

Gainers: Day One Biopharmaceuticals (DAWN) +103%. Redbox Entertainment (RDBXW) +85%. OptiNose (OPTN) +37%. Cerberus Cyber Sentinel Corporation (CISO) +36%. Ekso Bionics Holdings (EKSO) +35%. AeroClean Technologies (AERC) +33%. Redbox Entertainment (RDBX) +29%. Electro-Sensors (ELSE) +17%. Cyn...

Day One Biopharmaceuticals (NASDAQ: DAWN) has announced positive initial data for the first 22 Response Assessment for Neuro-Oncology evaluable patients enrolled in the on going phase 2 FIREFLY-1 clinical trial. Initial data from the first 25 patients enrolled ...

Gainers: Day One Biopharmaceuticals (DAWN) +111%. Ekso Bionics Holdings (EKSO) +22%. OptiNose (OPTN) +19%. Tivic Health Systems (TIVC) +10%. Belite Bio (BLTE) +7%. Losers: ContraFect (CFRX) -23%. Reviva Pharmaceuticals Holdings (RVPH) -20%. Neptune Wellness Solutions (NEPT) -19%. Sc...